Results 81 to 90 of about 407,552 (296)

Passive Transfer of Hepatitis B Antibodies through Intravenous Immunoglobulin in a Neonate

Acta Médica Portuguesa, 2019
Passive transfer of antibodies secondary to intravenous immunoglobulin infusion is a rare but important side effect that can lead to the wrong diagnosis and therapeutic decisions. It has never been reported in a newborn.
João Rato, Daniela Alves, Luís Rodrigues   +2 more
doaj   +1 more source

A machine learning approach to predict intravenous immunoglobulin resistance in Kawasaki disease patients: A study based on a Southeast China population.

PLoS ONE, 2020
Kawasaki disease is the leading cause of pediatric acquired heart disease. Coronary artery abnormalities are the main complication of Kawasaki disease.
Tengyang Wang, Guanghua Liu, Hongye Lin
doaj   +1 more source

Сorrection of patients’ immune status with human intravenous immunoglobulin

, 2017
The article is dedicated to administration of human intravenous immunoglobulin for patients with different pathology accompanied by immunity disorders.
N A Romanenko, A V Chechetkin, S S Bessmel’tsev   +2 more
core   +1 more source

A Case of a 40‐year‐old Female with Speech Disturbance

Annals of Clinical and Translational Neurology, EarlyView.
Victoria Lorah, Michael V. Robers
wiley   +1 more source

Nanomaterials for Allergy Diagnosis and Treatment: Advances, Opportunities and Translational Challenges

Advanced Science, EarlyView.
Nanomaterials offer dual applications in allergy management. For diagnosis, nanomaterials enhance analytical sensitivity and improve detection in specific IgE and functional assays such as the basophil activation test (BAT). For allergen‐specific immunotherapy, nanomaterials enable allergen masking and controlled release, and effectively modulate the ...
Madiha Habib, Shan Jiang, Joyce ZX Lee, CW Lim, HL Yeung, Nicki YH Leung, Patrick SC Leung, Ting F Leung, Christine YY Wai   +8 more
wiley   +1 more source

IVIG Resistance in Kawasaki Disease: Clinical and Laboratory Risk Factors and the Potential Role of Administration Timing

Journal of Inflammation Research
Yue Peng,1– 3,* Fengchuan Jing,1– 3,* Dong Liu,4 Bin Li,5 Yanxia Xu,6 Zhongyou Tan,7 Ouyang Chen,7 Yanfeng Yang,8 Feifei Si,8 Wenliang Jiang,9 Cong Li,9 Zhenli Cheng,1– 3 Xue Zhou,1– 3 Siqi Feng,1– 3 Ya Su,1– 3 Qijian Yi1– 3 1Department ...
Peng Y, Jing F, Liu D, Li B, Xu Y, Tan Z, Chen O, Yang Y, Si F, Jiang W, Li C, Cheng Z, Zhou X, Feng S, Su Y, Yi Q   +15 more
doaj  

EphB1‐Mediated Transient Blood‐Brain Barrier Opening Facilitates a Ferritin‐Based Nanotherapeutic for Alzheimer's Disease

Advanced Science, EarlyView.
We constructed a brain‐targeted AFn‐DPZ nanodrug delivery system and identified EphB1 as its receptor on the blood‐brain barrier (BBB). This system facilitates drug transport across the BBB and thereby ameliorates cognitive impairment in Alzheimer's disease.
Shilin Wen, Jingjing Gao, Zhixian Wang, Qiumin Ma, Xiao‐Ling Xu, Jianer Chen   +5 more
wiley   +1 more source

Severe pulmonary toxicity from immune checkpoint inhibitor treated successfully with intravenous immunoglobulin: Case report and review of the literature

Respiratory Medicine Case Reports, 2019
Immune checkpoint inhibitors are known to cause a variety of immune-related adverse events, including pneumonitis. When symptomatic, treatment typically consists of temporary or permanent cessation of the checkpoint inhibitor and several weeks of ...
Camille R. Petri, Rushad Patell, Felipe Batalini, Deepa Rangachari, Robert W. Hallowell   +4 more
doaj   +1 more source

Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review

, 2002
This review discusses the efficacy and safety in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) of intravenous immunoglobulin and compares this treatment with plasma exchange and prednisolone.
Vermeulen, M, de Haan, Rob, Winer, John B., IN van Schaik, JB Winer, R de Haan, de Haan, R. J., van Schaik, I. N., Vermeulen, M., van Schaik, Ivo N., van Schaik, IN, Winer, John, M Vermeulen, Vermeulen, Marinus, de Haan, R, Winer, J. B.   +15 more
core   +1 more source

Intravenous Immunoglobulin with Enhanced Polyspecificity Improves Survival in Experimental Sepsis and Aseptic Systemic Inflammatory Response Syndromes. [PDF]

, 2015
Sepsis is a major cause for death worldwide. Numerous interventional trials with agents neutralizing single pro-inflammatory mediators have failed to improve survival in sepsis and aseptic systemic inflammatory response syndromes. This failure could well
Dimitrova, Petya, Lubka Roumenina, Stefanova, Zvetanka, Bläss, Markus, Claus, Ralf, Bockmeyer, Clemens, Vassilev, Tchavdar, Ralf Claus, Ivanovska, Nina, Lindig, Sandro, Elisaveta Voynova, Jordan Dimitrov, Clemens Bockmeyer, Michael Bauer, Djoumerska-Alexieva, Iglika, Anastas Pashov, von Gunten, Stephan, Sandro Lindig, Pashov, Anastas, Voynova, Elisaveta, Catherine Fitting, Dimitrov, Jordan, Markus Bläss, Stephan von Gunten, Kaveri, Srini, Petya Dimitrova, Hadzhieva, Maya, Jean-Marc Cavaillon, Tchavdar Vassilev, Fitting, Catherine, Srini Kaveri, Roumenina, Lubka, Iglika Djoumerska-Alexieva, Zvetanka Stefanova, Nina Ivanovska, Cavaillon, Jean-Marc, Bauer, Michael, Maya Hadzhieva   +37 more
core   +3 more sources